[ARS] REVIVA PHARMACEUTICALS HOLDINGS, INC. SEC Filing

Filing Impact

(No impact)

Filing Sentiment

(Neutral)

Form Type

ARS

11/04/2025 - 04:21 PM

ARS - REVIVA PHARMACEUTICALS HOLDINGS, INC.

ARS Filing - REVIVA PHARMACEUTICALS HOLDINGS, INC.

This filing is available as a PDF document.

Filing Type: ARS

Company: REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH)

Acceptance Date: 2025-11-04T16:21:27.000Z

View PDF Document

Source: View Original Filing on SEC EDGAR

Reviva Pharmaceutcls Hldgs Inc

NASDAQ:RVPH

RVPH Rankings

#5373 Ranked by Market Cap

N/A Ranked by Dividends

#35 Top Gainer

RVPH Latest News

Oct 29, 2025

Reviva to Participate in the Spartan Capital Securities Second Annual Investor Conference

Oct 28, 2025

Reviva to Present Negative Symptom Data for Brilaroxazine in Schizophrenia from the Phase 3 RECOVER Double-Blind and Open-Label Extension Trials at the CNS Summit 2025

Oct 7, 2025

Reviva to Participate in Key Opinion Leader Webinar Hosted by Alliance Global Partners

Oct 2, 2025

Reviva to Participate in the 4th Annual Roth Healthcare Opportunities Conference

Sep 23, 2025

Reviva to Participate in the Lytham Partners Fall 2025 Investor Conference

RVPH Latest SEC Filings

Nov 4, 2025

[DEF 14A] REVIVA PHARMACEUTICALS HOLDINGS, INC. Definitive Proxy Statement

Oct 24, 2025

[PRE 14A] REVIVA PHARMACEUTICALS HOLDINGS, INC. Preliminary Proxy Statement

Oct 17, 2025

[8-K] REVIVA PHARMACEUTICALS HOLDINGS, INC. Reports Material Event

Sep 29, 2025

[SCHEDULE 13G] REVIVA PHARMACEUTICALS HOLDINGS, INC. SEC Filing

Sep 26, 2025

[8-K] REVIVA PHARMACEUTICALS HOLDINGS, INC. Reports Material Event

RVPH Stock Data

Market Cap 56.83M

Float 91.39M

Insiders Ownership 7.27%

Institutions Ownership 21.07%

Short Percent 19.28%

Industry Biotechnology

Sector Pharmaceutical Preparations

Website Link

Country United States

City CUPERTINO